Brokerages forecast that Transcat, Inc. (NASDAQ:TRNS) will report earnings of $0.19 per share for the current fiscal quarter, according to Zacks. Zero analysts have made estimates for Transcat’s earnings. Transcat reported earnings of $0.20 per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 5%. The company is expected to report its next earnings results on Tuesday, October 22nd.

On average, analysts expect that Transcat will report full year earnings of $0.92 per share for the current year. Zacks’ EPS calculations are an average based on a survey of analysts that cover Transcat.

Transcat (NASDAQ:TRNS) last posted its quarterly earnings results on Tuesday, July 23rd. The scientific and technical instruments company reported $0.23 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.02). The firm had revenue of $42.40 million for the quarter. Transcat had a return on equity of 12.84% and a net margin of 4.46%.

Several research analysts recently issued reports on TRNS shares. Zacks Investment Research cut shares of Transcat from a “hold” rating to a “strong sell” rating in a report on Tuesday, July 30th. ValuEngine cut shares of Transcat from a “buy” rating to a “hold” rating in a report on Thursday, August 1st.

NASDAQ TRNS traded down $0.36 during trading hours on Friday, hitting $22.11. 20,700 shares of the stock were exchanged, compared to its average volume of 32,554. The company has a market cap of $161.68 million, a price-to-earnings ratio of 23.27, a price-to-earnings-growth ratio of 3.01 and a beta of 0.72. Transcat has a 12-month low of $17.56 and a 12-month high of $27.00. The stock has a 50-day moving average of $23.96 and a 200 day moving average of $24.05. The company has a quick ratio of 1.38, a current ratio of 2.10 and a debt-to-equity ratio of 0.44.

In related news, Chairman Charles P. Hadeed sold 10,000 shares of the stock in a transaction dated Tuesday, June 18th. The shares were sold at an average price of $26.50, for a total transaction of $265,000.00. Following the completion of the transaction, the chairman now directly owns 50,993 shares of the company’s stock, valued at $1,351,314.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Carl E. Sassano sold 5,000 shares of the stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $24.85, for a total transaction of $124,250.00. Following the transaction, the director now directly owns 71,484 shares of the company’s stock, valued at $1,776,377.40. The disclosure for this sale can be found here. Insiders have sold 33,462 shares of company stock valued at $842,642 over the last three months. 8.90% of the stock is currently owned by corporate insiders.

A number of institutional investors and hedge funds have recently modified their holdings of the business. Essex Investment Management Co. LLC raised its position in shares of Transcat by 16.3% during the 2nd quarter. Essex Investment Management Co. LLC now owns 52,064 shares of the scientific and technical instruments company’s stock worth $1,332,000 after buying an additional 7,315 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of Transcat by 12.3% in the 2nd quarter. Vanguard Group Inc. now owns 298,719 shares of the scientific and technical instruments company’s stock worth $7,644,000 after purchasing an additional 32,636 shares during the last quarter. BlackRock Inc. grew its stake in shares of Transcat by 1,477.5% in the 2nd quarter. BlackRock Inc. now owns 366,492 shares of the scientific and technical instruments company’s stock worth $9,378,000 after purchasing an additional 343,259 shares during the last quarter. Northern Trust Corp grew its stake in shares of Transcat by 22.9% in the 2nd quarter. Northern Trust Corp now owns 30,708 shares of the scientific and technical instruments company’s stock worth $786,000 after purchasing an additional 5,712 shares during the last quarter. Finally, Ancora Advisors LLC grew its stake in shares of Transcat by 22.0% in the 2nd quarter. Ancora Advisors LLC now owns 268,160 shares of the scientific and technical instruments company’s stock worth $6,862,000 after purchasing an additional 48,368 shares during the last quarter. Institutional investors own 65.76% of the company’s stock.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Further Reading: What is Elliott Wave theory?

Get a free copy of the Zacks research report on Transcat (TRNS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.